FDA PMA 30-Day Notice Accepted 🇺🇸 United States

Pulmonary Valve Prosthesis Percutaneously Delivered

PMA: P200015 · Supplement: S051 · Decision Dec 14, 2023
Classifications
1
FEI Numbers
14
Registration Numbers
14

Basic Information

Device Name
Pulmonary Valve Prosthesis Percutaneously Delivered
Trade Name
Edwards SAPIEN 3 Transcatheter Heart Valve
PMA Number
P200015
Supplement Number
S051
Product Code
NPV
Generic Name
Pulmonary valve prosthesis percutaneously delivered
Medical Specialty
Unknown
Advisory Committee
Cardiovascular
Decision
30-Day Notice Accepted
Decision Code
OK30
Decision Date
December 14, 2023
Date Received
November 16, 2023
Supplement Type
30-Day Notice
Supplement Reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Expedited Review
N

Advisory Committee Statement

implementation of an automated sewing system

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
NPV Pulmonary Valve Prosthesis Percutaneously Delivered